Search criteria | ||||
Cost analysis of sequencing new agents for the treatment of chronic lymphocytic leukemia from the perspective of the Brazilian supplementary health system | ||||
Leandro Brust (1), Celso Arrais (2), Fabiano Pombo (3), Diego Kashiura (4), Pedro Vitor Pereira Lima (4), Ana Travassos (5), Rafael Silva (5), Straus Tanaka (5) | ||||
1: Dasa, Rio Grande do Sul, Brasil; 2: Universidade Federal de São Paulo, São Paulo, SP, Brasil; 3: Américas Centro de Oncologia Integrado, Rio de Janeiro, RJ, Brasil; 4: IQVIA Real World Insights Brazil, São Paulo, SP, Brasil; 5: AbbVie Brasil, São Paulo, SP, Brasil. | ||||
J Bras Econ Saúde 2022;14(1):80-8 |
||||
, Article | ||||
, Brazil | ||||
Abstract: https://jbes.com.br/wp-content/uploads/2022/05/JBES_141_80-88.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2022 | Portuguese | , Cost effectiveness | |
Predictors of iron‑deficiency anemia in primary care older adults: a real‑world European multi‑country longitudinal study | ||||
Vetrano DL, Zucchelli A, Marconi E, Levi M, Pegoraro V, Cataldo N, Heiman F, Cricelli C, Lapi F | ||||
Vetrano DL: Department of Geriatrics, Catholic University of Rome and IRCCS Fondazione Policlinico “A. Gemelli”, Rome, Italy. Pegoraro V: Medical Writer & HEOR Consultat, IQVIA, RWS, Milan, Italy. Heiman F: HEOR Engagement Manager, IQVIA, RWS, Milan, Italy | ||||
Aging Clin Exp Res (2020). https://doi.org/10.1007/s40520-019-01454-6 |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain | ||||
Abstract: https://link.springer.com/article/10.1007/s40520-019-01454-6 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2020 | English | , Epidemiological study, Retrospective database analysis | |
Évaluation de la population à risque d’hyperkaliémie | ||||
Gilles Berrut1 Anne-Sophie Boureau1 Laure de Decker1 Olivier Hanon2 | ||||
1 Pôle hospitalo-universitaire de gérontologie clinique, CHU Nantes, France 2 Hôpitaux universitaires Paris Centre, Service de gériatrie, Hôpital Broca, Université Paris-Descartes, Paris, France | ||||
10.1684/pnv.2020.0873 |
||||
, Article | ||||
Abstract: https://www.jle.com/fr/revues/gpn/e-docs/evaluation_de_la_population_a_risque_dhyperkaliemie__317258/article.phtml | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Hematology | 2020 | French | , Retrospective database analysis | |
Hospitalizations and outpatient vists (H&OV) in moderate and severe acute graft versus host disease (aGVHD) patients in Finland and Sweden | ||||
Itälä-Remes M1, Viayna E2, Nicklasson M3, Keränen M4, Thunström D5, Pfeiffer M5, Roset M2, Lara N2, Sabatelli L5 | ||||
1 Turku University Hospital, Finland 2 IQVIA, Real World Solutions, Barcelona, Spain 3 Sahlgrenska, University Hospital, Gothenburg, Sweden 4 Helsinki University Hospital, Finland 5 Incyte Biosciences International, Morges, Switzerland | ||||
ISPOR 2020 Annual European Congress. 14-18 November 2020. Milan, Italy |
||||
, Poster | ||||
, Finland, Sweden | ||||
Abstract: x | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Transplant | 2020 | English | , Population Based Study, Retrospective cohort analysis | |
Patient preferences, treatment satisfaction, and quality of life in newly diagnosed and relapsed/refractory multiple myeloma patients receiving injectable-containing or fully oral therapies: the EASEMENT study | ||||
Neil Rabin1, Rami Kotb2, Athanasios Zomas3, Alonso Fernandez-Nistal3, Rocco D’Ambrosio3, Nawal Bent-Ennakhil3, Montserrat Roset4, Ombretta Annibali5 | ||||
1 University College London Hospitals, London, and North Middlesex University Hospital, UK; 2 CancerCare Manitoba, Winnipeg, Manitoba, Canada; 3 Takeda Pharmaceuticals International AG, Zurich, Switzerland; 4 IQVIA, Barcelona, Spain; 5 Università Campus Bio-Medico di Roma, Rome, Italy | ||||
COMy (the 6th World Congress on Controversies in Multiple Myeloma), Virtual congress, 3-4 October 2020 |
||||
, Poster | ||||
, Canada, Italy, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2020 | English | , Population Based Study | |
Gender differences in determinants of iron-deficiency anemia: a population-based study conducted in four European countries | ||||
Levi M1, Simonetti M2, Marconi E2, Brignoli O3, Cancian M3, Masotti A4, Pegoraro V5, Heiman F5, Cricelli C3, Lapi F2 | ||||
1 Local Health Unit Tuscany Centre, Florence, Italy 2 Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy 3 Italian College of General Practitioners and Primary Care, Florence, Italy 4 Department of Transfusion Medicine, Pordenone, Italy 5 IQVIA, Milan, Italy | ||||
Annals of Hematology (2019) 98:15731582 |
||||
, Article | ||||
, Belgium, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries | ||||
Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi | ||||
IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK | ||||
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA. |
||||
, Poster | ||||
, Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland | ||||
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2019 | English | , Public Health, Survey research | |
The clinical and economic burden of cytomegalovirus management post allogeneic hematopoietic stem cell transplantation in Japan - a retrospective database study | ||||
Rie Ueno 1, Shinichi Nishimura 1, Go Fujimoto 1, Yi Piao 2, Katsuto Takenaka 3 (rwesheorj A) | ||||
1) MSD K.K., Tokyo, Japan 2) IQVIA Solutions Japan K.K., Tokyo, Japan 3) Department of Hematology, Clinical Immunology and Infectious Diseases, Graduate School of Medicine, Ehime University, Toon, Japan | ||||
Current Medical Research and Opinion |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2019.1649379 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Medication adherence/persistence and demographics of Japanese dyslipidemia patients on statin-ezetimibe as a separate pill combination lipid-lowering therapy- an observational pharmacy claims database study | ||||
Tatsuya Umeda 1, Ai Hayashi 1, Go Fujimoto 1, Yi Piao 2, Nobutomo Matsui 2, Shigeru Tokita 1 | ||||
1) Medical Affairs, MSD K.K. 2) Real World Insights, IQVIA Solutions Japan K.K. | ||||
Circulation Journal Circ J. 2019 Jul 25;83(8):1689-1697 |
||||
, Abstract, Article, Poster | ||||
, Japan | ||||
Abstract: https://www.jstage.jst.go.jp/article/circj/83/8/83_CJ-18-1344/_article | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
A budget impact analysis of anti-inhibitor coagulant complex use in pediatric hemophilia A patients with inhibitors across kingdom of Saudi Arabia | ||||
Al Jedai A1, AL-Mudaiheem H1, Al daamah S2, Al kasim F3, Wasri A4, Shaheen N5, Dawood E6, El-Hamaidi I7, Mohamed O8 | ||||
1Ministry of Health, Riyadh, NJ, USA, 2Ministry of Health, Damam, Saudi Arabia, 3Ministry of Health, Riyadh, Saudi Arabia, 4Ministry of National Guards, Jeddah, Saudi Arabia, 5King Faisal Specialized Hospitals, Damam, Saudi Arabia, 6Ministry of Health, Mekkah, Saudi Arabia, 7Ministry of National Guards, Riyadh, Saudi Arabia, 8IQVIA, Dubai, DU, United Arab Emirates | ||||
2019-11, ISPOR Europe 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Saudi Arabia | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3122/96011 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Rare disease | 2019 | English | , Budget impact | |
Cost of treating iron deficiency anaemia (ida) with ferric carboxymaltose versus iron saccharate in heavy uterine bleeding (hub) patients in the kingdom of Saudi Arabia | ||||
A. Alhejazi1, O. Mohamed2, M. Alhowimel1, M. Al Adham1 | ||||
Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia; Ministry of National Guard, Health Affairs, Riyadh, Saudi Arabia | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.824 |
||||
, Article | ||||
, Saudi Arabia | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)31016-2/abstract | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Womens Health | 2019 | English | , Budget impact, Predictive analytics | |
Health economic value of blood in Ivory coast: The case of maternal bleeding | ||||
Sekongo YM1, Asamoah-Akuoko L2, Owusu-Ofori SPO3, Lamotte M4, Bah A5, Dierick K5 | ||||
1 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan,Yvory Coast 2 National Blood Service, Accra, Ghana 3 Komfo Anokye Teaching Hospital, Kumasi, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
, Ivory Coast | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.1429 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Literature Review | |
Health economic vale of blood in Ghana: The case of maternal bleeding | ||||
Owusu-Ofori SPO1, Asamoah-Akuoko L2, Lamotte M3, Bah A4, Dierick K4 | ||||
1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 National Blood Service, Accra, Ghana 3 IQVIA, Zaventem, Belgium 4 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.1964 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Survey research | |
Health economic value of blood in Sub-Saharan: The case of maternal bleeding | ||||
Owusu-Ofori SPO1, Sekongo YM2, Rajab JA3, Asamoah-Akuoko L4, Magutu V5, Lamotte M6, Bah A7, Dierick K7 | ||||
1 Komfo Anokye Teaching Hospital, Kumasi, Ghana 2 DEA Biologie Humaine et Tropicale Unité de Thérapeutique Transfusionnelle Centre National de Tranfusion Sanguine DU de Biologie Transfusionnelle DU Gestion des infections et soins complementaires en Onco-Hématologie DU BIOSAS DU Reparation juridique du Do, Abidjan, Yvory Coast 3 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Kenya 4 National Blood Service, Accra, Ghana 5 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 6 IQVIA, Zaventem, Belgium 7 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.2059 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Survey research | |
The value of blood in sub-Saharan Africa | ||||
Magutu V1, Rajab A2, Asamoah-Akuoko L3, Lamotte M4, Bah A5, Dierick K5 | ||||
1 Department of Pathology Agar Khan Hospital, Nairobi, 110, Kenya 2 Haematology & Blood Transfusion Unit, Department of Human Pathology, School of Medicine, College of Health Sciences, University of Nairobi, Nairobi, Kenya 3 National Blood Service, Accra, Ghana 4 IQVIA, Zaventem, Belgium 5 Terumo BCT, Zaventem, Belgium | ||||
ISPOR, Copenhagen, Denmark, 4-6 November 2019 |
||||
, Poster | ||||
Abstract: https://doi.org/10.1016/j.jval.2019.09.2084 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2019 | English | , Cost analysis, Survey research | |
Patient characteristics and treatment patterns in multiple myeloma by treatment administration route and disease status: EASEMENT observational study | ||||
Rabin N1, Kotb R2, Zomas A3, Gonzalez F3, Fernandez-Nistal A3, D’Ambrosio R3, Bent-Ennakhil N3, Roset M4, Annibali O5 | ||||
1 University College Hospital, London, UK 2 Cancer Care Manitoba, Canada 3 Takeda Pharmaceuticals International AG, Switzerland 4 IQVIA, Barcelona, Spain 5 Università Campus Bio-Medico di Roma, Italy | ||||
IMW, Boston, US, 12-15 September 2019 |
||||
, Poster | ||||
, Canada, Italy, UK | ||||
Abstract: https://doi.org/10.1016/j.clml.2019.09.456 | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Hematology | 2019 | English | , Epidemiological study, Observational study | |
Clinical characteristics, treatment patterns, and thromboembolic risk of patients with cold agglutinin disease (CAD) in Japan | ||||
Toyomi Kamesaki 1, Jun-ichi Nishimura 2, Hideho Wada 3, Eric Yu 4, Elisa Tsao 5, Jaime Morales 5, Yuzuru Kanakura 2 (rwesheorj 4) | ||||
1) Jichi Medical University 2) Osaka University, Osaka, Japan 3) Kawasaki Medical School, Kurashiki, Japan 4) IQVIA, Tokyo, Japan 5) Sanofi, Waltham, MA, USA | ||||
European Hematology Association 2019 Conference |
||||
, Abstract, Poster | ||||
, Japan | ||||
Abstract: https://library.ehaweb.org/eha/2019/24th/266231/jun-ichi.nishimura.clinical.characteristics.treatment.patterns.and.html | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2019 | English | , Epidemiological study, Retrospective database analysis | |
LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION. | ||||
Allou A*, Carette J*, Minacori R*, Touahmia S*, Bourguignon S*, Troubat A*, Maurel F* | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology | 2018 | English | , Cost effectiveness, Market impact, Review | |
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden. | ||||
Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. | ||||
Henry N1, Jovanović J1, Schlueter M1, Kritikou P2, Wilson K2, Myrén KJ2. 1 IQVIA , London , UK. 2 Swedish Orphan Biovitrum AB , Stockholm , Sweden. | ||||
, Article | ||||
, Nordic, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Rare disease | 2018 | English | , Retrospective database analysis | |
Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease | ||||
Peyrin-Biroulet L1, Van Assche G2, Gómez-Ulloa D3, García-Álvarez L3, Lara N3, Black CM4, Kachroo S4. | ||||
1Gastroenterology Department, Lorraine University, Vandoeuvre, France. 2Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. 3IMS Health, Real-World Evidence Solutions, Barcelona, Spain. 4Center for Observational and Real-World Evidence (CORE), Merck and Co, Inc, Kenilworth, New Jersey. | ||||
: Clin Gastroenterol Hepatol. 2016 Jul 5. pii: S1542-3565(16)30372-X. doi: 10.1016/j.cgh.2016.06.025 |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Hematology | 2016 | English | , Review | |
Epidemiology of patients receiving hematopoietic stem cell patients in Belgium. | ||||
Chevalier P, Tsakeu E, Lamotte M | ||||
QuintilesIMS, Zaventem, Belgium | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2016 | English | ||
EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France. | ||||
Polack B1, Calvez T2, Chambost H3, Rothschild C4, Goudemand J5, Claeyssens S6, Borel-Derlon A7, Bardoulat I8, Maurel F8, Woronoff-Lemsi MC9; EQOFIX Study Group. | ||||
1Department of Hematology, University Hospital, and CNRS UMR5525, Grenoble-Alpes University, Grenoble, France. 2Sorbonne University, UPMC University of Paris 06, INSERM, UMR-S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France. 3APHM, Department of Pediatric Hematology, Children Hospital La Timone, and INSERM, UMR 1062, Aix-Marseille University, Marseille, France. 4Regional Hemophilia Center, Department of Hematology, University Hospital Necker Enfants Malades, Paris, France. 5Department of Hematology-Transfusion, University Hospital, Lille, France. 6Regional Hemophilia Center, Purpan Hospital, Toulouse, France. 7Regional Hemophilia and VWD Center, University Hospital, and INSERM U919, Caen, France. 8Department of Health Economics and Outcome Research, IMS Health, La Défense, France. 9Pharmacy, University Hospital, and INSERM UMR1098, Franche-Comté University, Besançon, France. | ||||
Transfusion (2015) |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25652955 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2015 | English | , Economic evaluation, Observational study, Quality of life | |
Use of ADH antagonists results in lower hospital resource usage: a retrospective cohort study | ||||
Paul Grant 1 , Clare Jamookeeah 2 , Penny Dhanjal 2 & Gethin Griffith 2 | ||||
1Royal Sussex County Hospital, Brighton, UK; 2Otsuka Pharmaceuticals (UK) Ltd, Wexham, UK. | ||||
Endocrine Abstracts (2015) 38 P20 | DOI: 10.1530/endoabs.38.P20 |
||||
, Abstract | ||||
, UK | ||||
Abstract: https://www.endocrine-abstracts.org/ea/0038/ea0038p20 | ||||
Condition | Year | Language | Analysis type | |
, Guidelines, Hematology, Methodology | 2015 | English | , Burden of illness, direct to patient research, Retrospective cohort analysis, Review | |
Diagnosis of pernicious anemia and the risk of pancreatic cancer. | ||||
Shah P, Rhim AD, Haynes K, Hwang WT & Yang YX | ||||
Memorial Sloan Kettering Cancer Center Department of Medicine, Gastroenterology and Nutrition Service | ||||
Pancreas. 2014 Apr;43(3):422-6. doi: 10.1097/MPA.0000000000000054 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015141/ | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2014 | English | , Retrospective database analysis | |
The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study | ||||
Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW | ||||
University of Nottingham Division of Epidemiology and Public Health | ||||
Thorax. 2014 Feb;69(2):161-7. doi: 10.1136/thoraxjnl-2013-203720. Epub 2013 Nov 4 |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24188926 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Vascular disease | 2014 | English | , Retrospective database analysis | |
Costes de los agentes estimulantes de la eritropoyesis en el tratamiento de la anemia inducida por quimioterapia en España: resultados preliminares procedentes de la adaptación de un estudio belga | ||||
Duran A1, Spaepen E2, Lamotte M3, Brosa M4, Gutiérrez L5, Restovic G6 | ||||
1IMS Health, London, 2SBD Analytics, Belgium, 3IMS Health, Belgium, 4Oblikue Consulting, Spain, 5Amgen SA, Spain, 6Independant Consultant, Spain | ||||
Pharmacoecon Span Res Artic (2014) 11:15–23 |
||||
, Article | ||||
, Spain | ||||
Abstract: https://link.springer.com/article/10.1007/s40277-013-0022-7 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2013 | Spanish | , Cost analysis | |
Cost-effectiveness of rivaroxaban for the treatment of pulmonary embolism and secondary prevention of venous thromboembolism – a UK perspective | ||||
McLeod E1, Guillermin A1, Hudson R1, Bamber L2, Muston D3, Lensing A2 | ||||
1IMS Health, London, United Kingdom, 2Bayer HealthCare Pharmaceuticals, Wuppertal, Germany, 3Bayer plc, Berkshire, United Kingdom | ||||
ISTH July 2013, The Netherlands |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.eventure-online.com/eventure/publicAbstractView.do?id=216996&congressId=6839 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2013 | English | , Cost effectiveness | |
Identification and qualitative assessment of real world data sources: example of lymphoma and multiple myeloma in Europe | ||||
Noibi S1, Bertwistle D1, MacDougall F1, Berger K2, Mehta J3, Trask P3 | ||||
1IMS Health, London, UK, 2IMS Health, Munich, Germany, 3Sanofi, Cambridge, MA, USA | ||||
ISPOR 16th Annual European Congress, 2013. PRM48. |
||||
, Abstract, Poster | ||||
, Europe | ||||
Abstract: http://www.ispor.org/Events/Posters.aspx?eventId=42&sess=V | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2013 | English | , Real World Data | |
Antithrombotic drugs and risk of hemorrhagic stroke in the general population. | ||||
García-Rodríguez LA, Gaist D, Morton J, Cookson C & González-Pérez A | ||||
Spanish Centre for Pharmacoepidemiological Research (CEIFE) | ||||
Neurology. 2013 Aug 6;81(6):566-74. doi: 10.1212/WNL.0b013e31829e6ffa. Epub 2013 Jul 10. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23843464 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Hematology | 2013 | English | , Retrospective database analysis | |
Investigation of the Effect of Deprivation on the Burden and Management of Venous Leg Ulcers: A Cohort Study Using the THIN Database. | ||||
Petherick ES, Cullum NA & Pickett KE. | ||||
Bradford Institute for Health Research | ||||
PLoS One 8(3):e58948 •DOI: 10.1371/journal.pone.0058948 |
||||
, Article | ||||
, UK | ||||
Abstract: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058948 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Hematology | 2013 | English | , Retrospective database analysis | |
Gilbert's syndrome and the risk of death: a population-based cohort study. | ||||
Horsfall LJ, Nazareth I, Pereira SP & Petersen I | ||||
UCL Research Department of Primary Care and Population Health | ||||
J Gastroenterol Hepatol. 2013 Oct;28(10):1643-7. doi: 10.1111/jgh.12279. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23701650 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Metabolic Disorders | 2013 | English | , Retrospective database analysis | |
Signal Refinement of Drug-Induced Thrombocytopenia using The Health Information Network (THIN) Database. | ||||
Liu K, Hauben M & Bate A | ||||
Pfizer | ||||
29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Montreal, Canada |
||||
, Poster | ||||
, UK | ||||
Abstract: http://csdmruk.cegedim.com/THINBibliography.pdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Hematology | 2013 | English | , Retrospective database analysis | |
Mortality after hemorrhagic stroke: data from general practice (The Health Improvement Network). | ||||
González-Pérez A, Gaist D, Wallander MA, McFeat G & García-Rodríguez LA | ||||
Spanish Centre for Pharmacoepidemiological Research (CEIFE) | ||||
Neurology. 2013 Aug 6;81(6):559-65. doi: 10.1212/WNL.0b013e31829e6eff. Epub 2013 Jul 10. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23843467 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Hematology | 2013 | English | , Retrospective database analysis | |
Health-related quality of life and annual direct medical costs of patients with haemophilia B in France : the EQOFIX study | ||||
Polack B 1, Calvez T 2, Claeyssens S 3, Chambost H 4, Derlon A 5, Goudemand J 6, Rotshild C 7, Maurel F 8, Woronoff-Lemsi MC 9 | ||||
1 Department of hematology, CHU Grenoble, Grenoble, France - 2 Inserm & UPMC, Paris, France - 3 Regional Haemophilia Treatment center, Toulouse, France - 4 Regional Haemophilia Treatment center, Marseille, France - 5 Regional Haemophilia Treatment center, Caen, France - 6 Regional Haemophilia Treatment center, Lille, France - 7 Regional Haemophilia Treatment center, Paris cedex 1, France - 8 IMS health, Puteaux, France - 9 Department of Pharmacy, Besançon, France | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Cost of illness, Prospective study, Quality of life | |
Hemoglobin Decline in Chemotherapy Patients Prior To and After Policy Changes Affecting Use of Erythropoiesis-stimulating Agents: 2006 - 2009 | ||||
Hill JW1, Cong Z1, Hess G1, McGarvey N1, Nordyke RJ1 | ||||
1IMS Health, Plymouth Meeting, PA 19462, USA | ||||
J Int Med Res. 2012 ;40 (4):1532-45 |
||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Burden of illness | |
Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries | ||||
Duran A1, Spaepen E2,Lamotte M3, Walter E4, Umuhire D5, Lucioni C6, Pinheir B7, Brosa M8, Pujol LKB9, Van Belle S10, Annemans L11 | ||||
1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Bekkevoort, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Pharmaeconomic Research, Health Economics, Vienna, Austria 5 IMS Health, Paris, France 6 Wolters Kluwer Health Italy, Milan, Italy 7 CISEP, Research Centre on the Portuguese Economy, Lisbon, Portugal 8 Oblikue Consulting, Barcelona, Spain 9 Amgen (Europe) GmbH, Zug, Switzerland 10 Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium 11 I-CHER, Ghent University, Brussels University (VUB), Ghent, Belgium | ||||
Journal of Medical Economics Vol. 15, No. 3, 2012, 1–10 |
||||
, Article | ||||
, Austria, Belgium, France, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Cost analysis | |
Health economics analysis of pegfilgrastim in the prophylaxis of febrile neutropenia (FN) in Italy. | ||||
G. Rosti 1, M. Lebboroni 1, A. Cerchiari 2, P. Katz 3 | ||||
1 Ospedale Regionale Azienda Unità Locale Socio Sanitaria n°9 di Treviso, Oncologia Medica, Treviso, Italy 2 Amgen Dompè SpA, Health Economics, Milano, Italy 3 CSD Medical Research S.r.l, Pharmacoepidemiology & Health Economics, Milano, Italy | ||||
17th Congress of European Association of Hospital Pharmacists, |
||||
, Poster | ||||
, Italy | ||||
Abstract: http://ejhp.bmj.com/content/19/2/172.2 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2012 | English | , Budget impact | |
Hemoglobin Decline in Cancer Patients Receiving Chemotherapy Without An Erythropoiesis-Stimulating Agent | ||||
Pirker R1, Pirolli M2, Quigley J2, Hulnick S2, Legg J3, Collins H3, Vansteenkiste J4 | ||||
1 Medical University Vienna, Vienna, AT 2 IMS Health, USA (Formerly SDI Health) 3 Amgen, Inc., Thousand Oaks, USA | ||||
Support Care Cancer DOI 10.1007/s00520-012-1617-2. September 2012. |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584249/ | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Burden of illness | |
Health-related quality of life and annual direct medical cost of patients with haemophilia B in France: the eqofix study. | ||||
Polack B1, Calvez T2, Chambost H3, Rothschild C4, Goudemand J5, Claeyssens S6, Borel-Derlon A7, Bardoulat I8, Maurel F8, Woronoff-Lemsi MC9 | ||||
1 Department of Hematology, University Hospital, and CNRS UMR5525, Grenoble-Alpes University, Grenoble, France 2 Sorbonne University, UPMC University of Paris 06, INSERM, UMR-S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France 3 APHM, Department of Pediatric Hematology, Children Hospital La Timone, and INSERM, UMR 1062, Aix-Marseille University, Marseille, France 4 Regional Hemophilia Center, Department of Hematology, University Hospital Necker Enfants Malades, Paris, France 5 Department of Hematology-Transfusion, University Hospital, Lille, France 6 Regional Hemophilia Center, Purpan Hospital, Toulouse, France 7 Regional Hemophilia and VWD Center, University Hospital, and INSERM U919, Caen, France 8 Department of Health Economics and Outcome Research, IMS Health, La Défense, France 9 Pharmacy, University Hospital, and INSERM UMR1098, Franche-Comté University, Besançon, France | ||||
ISPOR 15th Annual European Congress, 2012, 3-7 November, Berlin, Germany |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Clinical setting: hospital, Cost analysis, Observational study, Patient questionnaire, Prospective study, Quality of life | |
Cost and quality of life benefits of faster bleed resolution with an rFVIIa analogue: a mathematical simulation study for the German population. | ||||
Pokras SM. Petrilla AA. Weatherall J. Lee WC. | ||||
HEOR, IMS Consulting Group, USA; Novo Nordisk, Denmark | ||||
International Society for Pharmacoeconomics & Outcomes Research (ISPOR) 14th Annual European Congress, Madrid, Spain. November 7, 2011. |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2011 | English | , Cost effectiveness, Economic evaluation | |
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie: Analyse von Verordnungsdaten aus der Routineversorgung in Deutschland [Use of erythropoiesis-stimulating factors in the therapy of renal anemia: Analysis of prescription data of the German routine data] | ||||
Schöffski O1, Müller H-J2, Kostev K3, Claus V4 | ||||
1 Lehrstuhl für Gesundheitsmanagement Universität Erlangen-Nürnberg, Germany, 2 Medizinische Klinik III, Klinikum Fulda gAG, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt, Germany | ||||
Nieren- und Hochdruckkrankheiten 2011; 40(2):84-90 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Nephrology | 2011 | German | , Retrospective cohort analysis | |
The economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis | ||||
Pokras SM, Petrilla AA, Weatherall J, Lee WC. | ||||
IMS Consulting Group, USA. Novo Nordisk Denmark | ||||
Haemophilia |
||||
, Article | ||||
, USA | ||||
Abstract: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2516.2011.02623.x/full | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2011 | English | , Retrospective database analysis | |
Synchronization of Administrations of Chemotherapy and Erythropoiesis-Stimulating Agents and Frequency of Associated Health Care Visits | ||||
Hill J1, Shreay S2, McGarvey N2, De AP1, Hess GP1, Corey-Lisle P2 | ||||
1IMS Health (formally SDI Health), Plymouth Meeting, PA, USA, 2Amgen, Inc., Thousand Oaks, CA, USA | ||||
Value in Health Volume 14, Issue 3 , Page A173, May 2011 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Hematology | 2011 | English | ||
Rate of hemoglobin decline in patients receiving chemotherapy without an erythropoiesis-stimulating agent in the United States community setting. | ||||
Pirolli M, Collins H2, Quigley J1, Hulnick S1 | ||||
1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc., Thousand Oaks, USA | ||||
European Journal of Cancer, 2011 |
||||
, Abstract | ||||
, USA | ||||
Abstract: http://obroncology.com/imshealth/content/ESMO%202011_pPirolli_1669-A-2_v2%20copy.pdf | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2011 | English | , Retrospective database analysis | |
Iron deficiency anaemia and delayed diagnosis of colorectal cancer: a retrospective cohort study. | ||||
Damery S, Ryan R, Wilson S, Ismail T, Hobbs R. | ||||
Colorectal Dis. 2011 Apr;13(4):e53-60. doi: 10.1111/j.1463-1318.2010.02488.x. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21054747 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2011 | English | ||
Rate of Hemoglobin Decline in Patients Receiving Chemotherapy without an Erythropoiesis-Stimulating Agent in the United States Community Setting | ||||
Pirolli M1, Collins H2, Quigley J1, Hulnick S1 | ||||
1 IMS Health, USA (Formerly SDI Health) 2 Amgen, Inc., Thousand Oaks, USA | ||||
European Journal of Cancer, 2011 |
||||
, Abstract | ||||
Abstract: http://obroncology.com/imshealth/content/ESMO%202011_pPirolli_1669-A-2_v2%20copy.pdf | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2011 | English | , Retrospective database analysis | |
Relation of the first hypertension-associated event with medication, compliance and persistence in naive hypertensive patients after initiating monotherapy | ||||
Mathes J1, Kostev K2, Gabriel A1, Pirk O1, Schmieder RE3 | ||||
1 IMS HEALTH GmbH & Co. OHG, Nuremberg 2 IMS HEALTH GmbH & Co. OHG, Frankfurt 3 Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany | ||||
Int J Clin Pharmacol Ther, 2010, Vol. 48, No. 3: S.173-183 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Medication compliance | 2010 | English | , Retrospective cohort analysis | |
Prozesskostenanalyse in der Thromboembolieprophylaxe nach elektiver Hüft- und Kniegelenkersatzoperation [Process cost analysis for the prophylaxis of thromboembolism after an elective artificial hip and knee joint replacement surgery] | ||||
Lipp H‐P1, Stemmer V2, Kogler C2, Narayanan S3, Eckhard P3 | ||||
1 Eberhard Karls University Tübingen, Tübingen, Germany 2 IMS HEALTH GmbH & Co. OHG, Nuremberg, Germany 3 Bayer Vital GmbH, Leverkusen, Germany | ||||
2nd annual conference of the Deutschen Gesellschaft für Gesundheitsökonomie (dggö) [German Association for Health Economics], Berlin, Germany, 1.-2.- March, 2010 |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | German | , Cost analysis | |
Treatment cost of hemophilia patients with inhibitors in the National Health System in Morocco | ||||
El Khorassani M, Hadjkhalifa H, By Z, Plun-Favreau J, Lindner L, Prior M. | ||||
Espérance Méd 2010; 17: 101-7. |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | Spanish | , Cost effectiveness | |
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie: Analyse von Verordnungsdaten aus der Routineversorgung in Deutschland | ||||
Schöffski O1, Müller H-J2, Kostev K3, Claus V4 | ||||
1 Lehrstuhl für Gesundheitsmanagement Universität Erlangen-Nürnberg, Germany, 2 Medizinische Klinik III, Klinikum Fulda gAG, Germany, 3 IMS Health GmbH & Co. OHG, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt, Germany | ||||
Nieren- und Hochdruckkrankheiten; XX, 2010 (accepted) |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Nephrology | 2010 | English | , Retrospective cohort analysis | |
Cost-utility analysis of dasatinib as a second line treatment in the chronic phase of chronic myeloid leukaemia in Russia | ||||
Kuznetzov S1, Mungapen L2, Samyshkin Y2, Jakouloff D3, Sbarigia U4, van Baardewijk M4 | ||||
1 Haematology Research Centre, Moscow, Russia, 2 IMS Health, London, UK, 3 BMS, Moscow, Russia, 4 BMS, Braine L’Alleud, Belgium | ||||
ISPOR 13th Annual European Congress, 6-9 November 2010, Prague Congress Centre, Prague, Czech Republic. |
||||
, Poster | ||||
, Russian Federation | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2010 | English | , Cost utility | |
The economic consequences of ineffective inpatient on-demand treatment for haemophilia with inhibitors: a US retrospective data analysis. | ||||
Pokras SM1. Weatherall J2. Petrilla AA1. Lee WC1. | ||||
1 IMS Health, Alexandria, US 2 Novo Nordisk | ||||
World Federation of Hemophilia Congress 2010, Buenos Aires, Argentina, July 2010 |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Retrospective database analysis | |
Potential cost savings associated with faster bleeding resolution in the inpatient treatment of haemophilia with inhibitors. | ||||
Weatherall J1, Munakata J2, Lee WC2 | ||||
1 Novo Nordisk A/S, Soborg, Denmark 2 IMS Health, Falls Church VA, US | ||||
ISPOR 4th Asia-Pacific Conference, 2010, September 5-7, Phuket, Thailand |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Cost analysis | |
Optimizing treatment strategies for acute bleeds in haemophilia with inhibitors: long-term impact of early treatment decisions. | ||||
Munakata J1, Kowal S1, Weatherall J2, Lee WC1 | ||||
1 IMS Health, Falls Church, VA 2 Novo Nordisk A/S, Soborg, Denmark | ||||
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Economic evaluation | |
Medical cost savings associated with a reduced need for re-treatment and fewer infusions required per bleed in the management of on-demand bleeds in haemophilia patients with inhibitors. | ||||
Kowal S1, Munakata J1, Weatherall J2, Lee WC1 | ||||
1 IMS Health, Falls Church, VA 2 Novo Nordisk A/S, Soborg, Denmark | ||||
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Economic evaluation | |
Impact of faster bleeding resolution on health-related quality of life (HRQoL) and quality adjusted life years (QALYs) in haemophilia patients with inhibitors. | ||||
Kowal S1, Munakata J1, Weatherall J2, Lee WC1 | ||||
1 IMS Health, Falls Church, VA, US 2 Novo Nordisk A/S, Soborg, Denmark | ||||
The XXIX International Congress of the World Federation of Hemophilia, 2010, July 10-14, Buenos Aires, Argentina |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Economic evaluation | |
Effect of Reimbursement Changes on Erythropoiesis-Stimulating Agent Utilization and Transfusions | ||||
Hess, G., Nordyke, R. J., Hill, J., Hulnick, S. | ||||
American Journal of Hematology |
||||
, Abstract | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Retrospective database analysis | |
Iron deficiency anaemia and delayed diagnosis of colorectal cancer: a retrospective cohort study | ||||
Damery S, Ryan R, Wilson S, Ismail T & Hobbs FR | ||||
Primary Care Clinical Sciences, School of Health and Population Sciences, University of Birmingham | ||||
Colorectal Disease doi: 10.1111/j.1463-1318.2010.02488.x |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2010 | English | , Retrospective database analysis | |
[Coste-efectividad de la identificación genética en pacientes en tratamiento con acenocumarol] Genotyping in patients in treatment with acenocumarol cost-effectiveness. | ||||
Lindner L, Lara N, Tàssies D, Tejedor D, Jofre-Monseny L | ||||
Lindner L1, Lara N1, Tàssies D2, Tejedor D3, Jofre-Monseny L3. 1Health Economics & Outcomes Research - IMS Health; 2Servicio de Hemoterapia y Hemostasia.Hospital Clínic Barcelona. 3 Progenika Biopharma S.A | ||||
, Article, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2009 | Spanish | , Cost effectiveness | |
Cost Study of Haemophilia in Morocco | ||||
Plun-Favreau J1, By Z2, Lindner L3, Prior M3 | ||||
1Novo Nordisk Pharma S.A.S., Zurich Oerlikon, Switzerland, 2Novo Nordisk Pharma S.A.S., Casablanca, Morocco, 3IMS Health, Barcelona, Spain | ||||
ISPOR 12th Annual European Congress 2009, 24 to 27 October, Paris, France |
||||
, Oral presentation | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2009 | English | , Cost analysis | |
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain. | ||||
Mayordomo JI, López A, Viñolas N, Castellanos J, Pernas S, Domingo Alonso J, Frau A, Layola M, Antonio Gasquet J, Sánchez J; ENIA Study Group. | ||||
1 Clínico Lozano Blesa, Zaragoza, Spain 2 Vall d’Hebron, Barcelona, Spain 3 Clínic i Provincial, Barcelona, Spain 4 Xeral-Cíes, Vigo, Spain 5 Institut Català d’Oncologia, L’Hospitalet-Barcelona, Spain 6 Virgen de la Arrixaca, Murcia, Spain 7 Provincial de Castellón, Castellón, Spain 8 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain 9 Amgen S.A., Barcelona, Spain | ||||
Curr Med Res Opin. 2009 Oct;25(10): 2533-42. |
||||
, Article | ||||
, Spain | ||||
Abstract: http://informahealthcare.com/doi/abs/10.1185/03007990903209563 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2009 | English | , | |
Verbrauch von Erythropoese-stimulierenden Faktoren in der Therapie der renalen Anämie - eine „real life“- Analyse der Versorgungssituation in Deutschland [Consumption of erythropoietin-stimulating factors in the renal anaemia therapy - a "real life"-analysis of the German medical treatment situation] | ||||
Schöffski O1, Müller H-J2, Kostev K3, Claus V4 | ||||
1 University Erlangen-Nuremberg, Nuremberg, Germany 2 Med. Klinik III Klinikum Fulda gAG, Fulda, Germany 3 IMS Health, Frankfurt, Germany 4 IMS Health, Munich, Germany | ||||
Congress for nephrology, Göttingen, Germany, 26-29 September 2009 |
||||
, Abstract, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology, Nephrology | 2009 | German | , Retrospective database analysis | |
Trajectory of Hemoglobin (Hb) in Patients Receiving Erythropoiesis-Stimulating Agents (ESAs) for Anemia Due to Concomitantly Administered Myelosuppressive Chemotherapy (CIA) | ||||
Hill J1, Cong Z2, Hess G1, Nordyke R2 | ||||
1IMS Health, Former SDI, Plymouth Meeting, PA 2Global Health Economics, Amgen Inc., Thousand Oaks, CA | ||||
American Society of Hematology December 5, 2009 |
||||
, Poster | ||||
Abstract: https://ash.confex.com/ash/2009/webprogram/Paper24805.html | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2009 | English | ||
The importance of clinical variables in comparative analyses using propensity-score matching: the case of ESA costs for the treatment of chemotherapy-induced anaemia. | ||||
Polsky D1, Eremina D2, Hess G12, Hill J2, Hulnick S2, Roumm A2, Whyte JL3, Kallich J3 | ||||
1University of Pennsylvania, Philadelphia, PA, USA, 2IMS Health (Former SDI Health),Plymouth Meeting, PA, USA, 3Amgen Inc., Thousand Oaks, California, USA | ||||
Pharmacoeconomics. 2009;27(9):755-65 |
||||
, Article | ||||
Abstract: http://link.springer.com/article/10.2165%2F11313860-000000000-00000 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Hematology | 2009 | English | , Cost analysis, Cost effectiveness, Quality of life | |
Erythropoiesis stimulating agent (ESA) administration at Hb <10 g/dL for chemotherapy-induced anemia (CIA) following the National Coverage Decision (NCD) | ||||
Hulnick SA, Hess G, Hill J, Viswanathan HN, Nordyke RJ | ||||
IMS Health, (Former Surveillance Data, Inc.), Plymouth Meeting, PA; Leonard Davis Institute, University of Pennsylvania, Plymouth Meeting, PA; Amgen, Inc., Thousand Oaks, CA | ||||
J Clin Oncol 27, 2009 (suppl; abstr e20627) |
||||
, Abstract | ||||
Abstract: http://meetinglibrary.asco.org/content/35272-65 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2009 | English | , Burden of illness, Quality of life, Retrospective cohort analysis | |
Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. | ||||
Arellano FM, Arana A, Wentworth CE, Fernández-Vidaurre C, Schlienger RG & Conde E | ||||
Risk MR, LLC, Bridgewater, NJ, USA | ||||
J Allergy Clin Immunol. 2009 May;123(5):1111-6, 116.e1-13. doi: 10.1016/j.jaci.2009.02.028. Epub 2009 Apr 10. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19361841 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Hematology, Oncology | 2009 | English | , Retrospective database analysis | |
The incidence of and mortality from leukaemias in the UK: a general population-based study | ||||
Bhayat F, Das-Gupta E, Smith C, McKeever T & Hubbard R | ||||
Division of Epidemiology and Public Health, University of Nottingham | ||||
BMC Cancer 2009, 9:252 |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.biomedcentral.com/1471-2407/9/252 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2009 | English | , Retrospective database analysis | |
Impact de la mise sur le marché d’une nouvelle érythropoïétine à injection mensuelle en termes de gain de temps et d’optimisation organisationnelle pour les personnels impliqués dans le circuit de l’EPO dans les centres d’hémodialyse. | ||||
Allard B., Grégoire M., Ferrandini C., Ollivier C., Vrtovsnik F., Zambrowski JJ., Mouradian A. | ||||
les Journées Annuelles de la Société de Néphrologie et de la Société francophone de dialyse ». 26-29 novembre 2008 |
||||
, Abstract, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | French | , Survey research | |
Assessment of the benefits of time savings achieved by once monthly injection of erythropoietin stimulating agents (ESA) on anaemia management in haemodialysis centres | ||||
Allard B., Grégoire M., Ferrandini C., Ollivier C., Vrtovsnik F., Zambrowski JJ., Lamure E, Baillon N | ||||
ISPOR congress. 8-11 November 2008 |
||||
, Abstract, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | English | , Survey research | |
Health and Economic Consequences of Pathogen Transmission Risk in the Treatment of Haemophilia A with Factor Viii | ||||
Asukai Y1, Lloyd AC1, Ghatnekar O2, Hutchings AS3 | ||||
1 IMS Health, London, UK 2 The Swedish Institute for Health Economics, Lund, Sweden 3 Baxter Healthcare, Newbury, UK | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008. |
||||
, Oral presentation | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | English | , Burden of illness | |
Epidemiology of idiopathic thrombocytopenic purpura in Belgium assessed using hospital records. | ||||
Gerlier L1, De Vos C1, Lamotte M1, Malfait M2, Poitrinal P3 | ||||
1 IMS Health, Brussels, Belgium 2 Amgen, Brussels, Belgium 3 Amgen, Zug, Switzerland | ||||
ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | English | , Epidemiological study | |
A health economic evaluation of the use of erythropoiesis-stimulating agents (ESA) in patients with renal failure treated with haemodialysis. | ||||
Van Bellinghen LA1, Lamotte M1, Malfait M2 | ||||
1 IMS Health, Brussels, Belgium 2 Amgen, Brussels, Belgium | ||||
ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece |
||||
, Abstract | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | English | , Economic evaluation | |
Cost-effectiveness of enoxaparin as prophylactic therapy versus unfractionated heparin or no prophylaxis in hospitalised medical patients | ||||
Feng J, Yuen C, Jackson D | ||||
ISPOR 11th Annual European Congress 8–11 November 2008 Athens Greece ISPOR 11th Annual European Congress, Athens Greece. November 2008 |
||||
, Oral presentation, Poster | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Vascular disease | 2008 | English | , Cost effectiveness | |
Myelodysplastic Syndromes: Aspects of current medical care and economic considerations in Germany | ||||
Gattermann N 1, Hofmann WK 2, Meeßen A 3, Schmitz S 4, Tsamaloukas A 5, Vollmer T 6, Wedding U 7, Plesnila-Frank C 8, Schramm W 9, Berger K 8 | ||||
1 Universitätsklinukum Düsseldorf,Germany 2 Charité Campus Benjamin Franklin, Berlin, Germany 3 Verband der Angestellten-Krankenkassen e.V. / Arbeiter-Ersatzkassen-Verband e.V., Siegburg, Germany 4 Hämatologe/Onkologe, Cologne, Germany 5 Internist/Onkologe, Hilden, Germany 6 Psycho-Onkologin, Rotterdam, Netherlands 7 Universitätsklinikum Jena, Germany 8 IMS Health, Munich, Germany 9 Klinikum der Universität München, Munich, Germany | ||||
Onkologie 2008; 31: 477-84. |
||||
, Article | ||||
, Germany | ||||
Abstract: http://content.karger.com/produktedb/produkte.asp?doi=142900 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | English | , Workshop | |
The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records. | ||||
Hamilton W, Lancashire R, Sharp D, Peters T J, Cheng K & Marshall T | ||||
Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol | ||||
Br J Cancer. 2008 Jan 29;98(2):323-7. doi: 10.1038/sj.bjc.6604165. Epub 2008 Jan 22. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18219289 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2008 | English | , Retrospective database analysis | |
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in Spain. | ||||
Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Piñol C4, Febrer L4 | ||||
1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer HealthCare, Barcelona, Spain | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, |
||||
, Poster | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2007 | English | , Cost effectiveness | |
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in the UK. | ||||
Diamantopoulos A1, Forster F1, Lees M2, Gilmour L3, Ashley D4 | ||||
1IMS Health, London, UK, 2Bayer HealthCare, Uxbridge, UK, 3Bayer Healthcare Pharmaceuticals Inc, Newbury, Berkshire, UK, 4Bayer Healthcare Pharmaceuticals Inc, Newbury, UK | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,2008 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2007 | English | , Cost effectiveness | |
Prophylaxis with Rivaroxaban against Venous Thromboembolism (VTE): A Cost-Consequence Analysis from the perspective of the Italian Healthcare Service. | ||||
Negrini C1, Diamantopoulos A2, Forster F2, Lopatriello S3, Lees M4, Bianchi C5, Pedone MP5 | ||||
1PBE Consulting, Milano, Italy, 2IMS Health, London, UK, 3Pbe Consulting, Verona, Italy, 4Bayer HealthCare, Uxbridge, UK, 5Bayer HealthCare, Milan, Italy | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008 |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2007 | English | , Cost consequence | |
Assesment of the economic value of the INTERCEPT blood system in Belgium. | ||||
Moeremans K, Warie H, Annemans L | ||||
Transfus Med.; 16:17-30 |
||||
, Manuscript in preparation | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2006 | English | ||
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting | ||||
Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R & Vallance P | ||||
Department of Epidemiology, London School of Hygiene and Tropical Medicine | ||||
Lancet. 2006 Apr 1;367(9516):1075-9. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/16581406 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Respiratory disease | 2006 | English | , Retrospective database analysis | |